NO921839L - Fremgangsmaate for isolering av faktor viii - Google Patents

Fremgangsmaate for isolering av faktor viii

Info

Publication number
NO921839L
NO921839L NO92921839A NO921839A NO921839L NO 921839 L NO921839 L NO 921839L NO 92921839 A NO92921839 A NO 92921839A NO 921839 A NO921839 A NO 921839A NO 921839 L NO921839 L NO 921839L
Authority
NO
Norway
Prior art keywords
factor viii
procedure
insulating factor
proteins
plasma
Prior art date
Application number
NO92921839A
Other languages
English (en)
Other versions
NO921839D0 (no
NO180741C (no
NO180741B (no
Inventor
Per Kaersgaard
Original Assignee
Novo Nordisk As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Nordisk As filed Critical Novo Nordisk As
Publication of NO921839D0 publication Critical patent/NO921839D0/no
Publication of NO921839L publication Critical patent/NO921839L/no
Publication of NO180741B publication Critical patent/NO180741B/no
Publication of NO180741C publication Critical patent/NO180741C/no

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/745—Blood coagulation or fibrinolysis factors
    • C07K14/755—Factors VIII, e.g. factor VIII C (AHF), factor VIII Ag (VWF)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Amplifiers (AREA)
  • Cephalosporin Compounds (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Networks Using Active Elements (AREA)
  • External Artificial Organs (AREA)
  • Separation Using Semi-Permeable Membranes (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO921839A 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII NO180741C (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DK562189A DK162233C (da) 1989-11-09 1989-11-09 Fremgangsmaade til isolering af faktor viii fra blodplasma og pharmaceutisk praeparat indeholdende den saaledes isolerede fator viii
PCT/DK1990/000279 WO1991007438A1 (en) 1989-11-09 1990-11-05 A method for isolating factor viii

Publications (4)

Publication Number Publication Date
NO921839D0 NO921839D0 (no) 1992-05-08
NO921839L true NO921839L (no) 1992-07-08
NO180741B NO180741B (no) 1997-03-03
NO180741C NO180741C (no) 1997-06-11

Family

ID=8144000

Family Applications (1)

Application Number Title Priority Date Filing Date
NO921839A NO180741C (no) 1989-11-09 1992-05-08 Fremgangsmåte for isolering av Faktor VIII

Country Status (26)

Country Link
US (1) US5245014A (no)
EP (1) EP0524172B1 (no)
JP (1) JP2509407B2 (no)
CN (1) CN1044121C (no)
AT (1) ATE118508T1 (no)
AU (1) AU631471B2 (no)
BG (1) BG61231B1 (no)
CA (1) CA2073012C (no)
CZ (1) CZ537190A3 (no)
DE (1) DE69017050T2 (no)
DK (1) DK162233C (no)
ES (1) ES2068404T3 (no)
FI (1) FI103510B (no)
HU (1) HU214905B (no)
IE (1) IE66836B1 (no)
IL (1) IL96277A (no)
NO (1) NO180741C (no)
NZ (1) NZ236004A (no)
PL (1) PL164894B1 (no)
PT (1) PT95830B (no)
RU (1) RU2055593C1 (no)
SK (1) SK537190A3 (no)
UA (1) UA29421C2 (no)
WO (1) WO1991007438A1 (no)
YU (1) YU47524B (no)
ZA (1) ZA908599B (no)

Families Citing this family (23)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0399321B1 (en) * 1989-05-24 1993-06-23 Miles Inc. Gel filtration of heat treated factor viii
US5888974A (en) * 1992-04-07 1999-03-30 Emory University Hybrid human/animal factor VIII
US6180371B1 (en) 1996-06-26 2001-01-30 Emory University Modified factor VIII
US5859204A (en) * 1992-04-07 1999-01-12 Emory University Modified factor VIII
US5659017A (en) * 1995-11-07 1997-08-19 Alpha Therapeutic Corporation Anion exchange process for the purification of Factor VIII
US7560107B2 (en) 1996-06-26 2009-07-14 Emory University Modified factor VIII
US6458563B1 (en) 1996-06-26 2002-10-01 Emory University Modified factor VIII
US6531577B1 (en) * 1997-12-15 2003-03-11 Hemasure Denmark A/S von Willebrand factor (vWF)-containing preparation, process for preparing vWF-containing preparations, and use of such preparations
US6290527B1 (en) * 1998-07-03 2001-09-18 Nippon Telegraph And Telephone Corp. Nippon telegraph and telephone corporation
BR0008405B1 (pt) 1999-02-22 2014-04-22 Baxter Int Composição de fator viii formulada sem a adição de albumina, uso de uma composição de fator viii, e, método de liofilizar uma formulação farmacêutica aquosa
JP2002348300A (ja) * 1999-04-12 2002-12-04 Fujimori Kogyo Co Ltd 血液凝固第ｖｉｉｉ因子および血液凝固第ｖｉｉｉ因子／フォン・ビルブラント因子複合体の精製方法
AUPR638801A0 (en) * 2001-07-13 2001-08-09 Life Therapeutics Limited Factor viii separation
PL1750733T3 (pl) 2004-05-03 2014-05-30 Univ Emory Sposób podawania świńskiego czynnika krzepnięcia VIII pozbawionego domeny B
WO2006021584A2 (en) * 2004-08-27 2006-03-02 Novo Nordisk Health Care Ag Purification of factor xiii polypeptides from biological materials
US20060226086A1 (en) * 2005-04-08 2006-10-12 Robinson Thomas C Centrifuge for blood processing systems
US20100168018A1 (en) * 2008-11-07 2010-07-01 Baxter International Inc. Factor viii formulations
DK3133157T3 (da) * 2010-03-30 2019-08-12 Octapharma Ag Fremgangsmåde til oprensning af vitamin k-afhængige proteiner
RU2445974C2 (ru) * 2010-04-26 2012-03-27 Учреждение Российской академии медицинских наук Гематологический научный центр ГНЦ РАМН Способ получения концентрата фактора viii из плазмы крови человека
EP2635297B1 (en) 2010-11-05 2019-02-27 Baxalta GmbH A new variant of antihemophilic factor viii having increased specific activity
WO2012082933A1 (en) 2010-12-15 2012-06-21 Baxter International, Inc. Eluate collection using conductivity gradient
CN103506080A (zh) * 2012-06-19 2014-01-15 汪志友 一种用于分离纯化凝血因子viii的介质及其制备方法
US11078518B2 (en) * 2012-09-28 2021-08-03 Chugai Seiyaku Kabushiki Kaisha Method for evaluating blood coagulation reaction
US9663553B2 (en) * 2014-01-29 2017-05-30 Hemarus Therapeutics Limited Integrated process for the production of therapeutics (human albumin, immunoglobulins, clotting factor VIII and clotting factor IX) from human plasma

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4495175A (en) * 1982-08-05 1985-01-22 University Of Rochester Preparation of highly purified human antihemophilic factor
US4543210A (en) * 1984-10-04 1985-09-24 Miles Laboratories, Inc. Process for producing a high purity antihemophilic factor concentrate
DK525384D0 (da) * 1984-11-05 1984-11-05 Nordisk Insulinlab Praeparat paa basis af faktor viii til behandling af haemofili a inhibitorpatienter samt fremgangsmaade til fremstilling af et saadan praeparat
US4847362A (en) * 1985-02-01 1989-07-11 New York University Method for purifying antihemophilic factor
US4675385A (en) * 1985-03-27 1987-06-23 Alpha Therapeutic Corporation Isolation of human plasma procoagulant protein factor VIII from biological factors
US4758657A (en) * 1985-07-11 1988-07-19 Armour Pharmaceutical Company Method of purifying Factor VIII:C
AT391808B (de) * 1986-11-03 1990-12-10 Immuno Ag Verfahren zur herstellung einer faktor viii (ahf)-haeltigen fraktion
EP0321835B1 (en) * 1987-12-21 1994-09-28 Miles Inc. Gel filteration of factor VIII
WO1989009784A1 (en) * 1988-04-08 1989-10-19 Commonwealth Serum Laboratories Commission Production of heat-stable factor viii concentrate
EP0399321B1 (en) * 1989-05-24 1993-06-23 Miles Inc. Gel filtration of heat treated factor viii

Also Published As

Publication number Publication date
HU214905B (hu) 1998-07-28
PT95830B (pt) 1997-11-28
ATE118508T1 (de) 1995-03-15
JP2509407B2 (ja) 1996-06-19
NZ236004A (en) 1991-11-26
CA2073012A1 (en) 1991-05-10
DK562189A (da) 1991-05-10
UA29421C2 (uk) 2000-11-15
CZ537190A3 (cs) 1998-05-13
DE69017050T2 (de) 1995-06-14
CN1051732A (zh) 1991-05-29
SK278640B6 (en) 1997-12-10
DK562189D0 (da) 1989-11-09
PT95830A (pt) 1991-09-30
RU2055593C1 (ru) 1996-03-10
HUT60511A (en) 1992-09-28
FI103510B1 (fi) 1999-07-15
FI922105A (fi) 1992-05-08
NO921839D0 (no) 1992-05-08
YU210590A (sh) 1993-05-28
IE66836B1 (en) 1996-02-07
IL96277A0 (en) 1991-08-16
NO180741C (no) 1997-06-11
YU47524B (sh) 1995-10-03
DK162233C (da) 1992-03-16
JPH05501557A (ja) 1993-03-25
IE904022A1 (en) 1991-05-22
ES2068404T3 (es) 1995-04-16
DE69017050D1 (de) 1995-03-23
BG61231B1 (en) 1997-03-31
DK162233B (da) 1991-09-30
SK537190A3 (en) 1997-12-10
US5245014A (en) 1993-09-14
NO180741B (no) 1997-03-03
IL96277A (en) 1995-07-31
CN1044121C (zh) 1999-07-14
AU6747090A (en) 1991-06-13
FI922105A0 (fi) 1992-05-08
BG96316A (bg) 1993-12-24
HU9201551D0 (en) 1992-08-28
FI103510B (fi) 1999-07-15
WO1991007438A1 (en) 1991-05-30
PL164894B1 (pl) 1994-10-31
EP0524172B1 (en) 1995-02-15
AU631471B2 (en) 1992-11-26
ZA908599B (en) 1991-07-31
PL287703A1 (en) 1991-12-02
CA2073012C (en) 1996-03-19
EP0524172A1 (en) 1993-01-27

Similar Documents

Publication Publication Date Title
NO921839D0 (no) Fremgangsmaate for isolering av faktor viii
YU191387A (en) Process for extracting lipofilic proteins from host cells of pichia origin
AU584576B2 (en) Process for separation of hydrocarbon gases
AU580494B2 (en) Process for the extraction and purification of proteins from culture media producing them
AU8006387A (en) Process for separation of hydrocarbon gases
ATE72121T1 (de) Verfahren zur herstellung von apolipoproteinen aus blutplasma- oder serumfraktionen.
AU6794387A (en) Centrifugal method of separating blood components
HU895859D0 (en) Process for separating of foline acid
GB2218991B (en) Enzymatic membrane method for the synthesis of peptides and the separation of optical isomers
AU584578B2 (en) Process for separation of hydrocarbon mixtures
AU582497B2 (en) Improved process for separation of acid gases
PT84879A (en) Process for the production of hybrid polypetides from bacterial clones comprising somatocrinine and alpha 1-antitrypsin and process for the production of somatocrinine
EP0256214A3 (en) Process for separation of water-insolouble distillates from water vapour
EP0213814A3 (en) Synthesis of tricyclazole
EP0256812A3 (en) Process for separation of n-protected -alpha-l-aspartyl-l-phenylalines
ATE66931T1 (de) Verfahren zur scheidung und isolierung von nosiheptid.
AU6385886A (en) Production of ige-binding protein by recombinant methods
KR920701461A (ko) 펩티드의 합성 및 분리를 위한 효소막법
AU1929188A (en) Process for recovery of gold
DK690587A (da) Tetrapeptid, dets fremstilling og anvendelse
BG44094A1 (en) Method for separating of furfurol from hydrolysate

Legal Events

Date Code Title Description
MM1K Lapsed by not paying the annual fees

Free format text: LAPSED IN MAY 2003